Information Provided By:
Fly News Breaks for May 18, 2017
TMO
May 18, 2017 | 16:09 EDT
Cantor Fitzgerald analyst Bryan Brokmeier initiated Thermo Fisher with an Overweight rating, as he sees significant opportunity for organic growth and for M&A. He set a $194 price target on Thermo Fisher, which he calls a "key beneficiary" of continued strength in biopharma.